等待开盘 04-01 09:30:00 美东时间
+1.960
+2.12%
今日重点评级关注:Maxim Group:上调Theriva Biologics评级至"买入",目标价1美元;HC Wainwright & Co.:维持Bicara Therapeutics"买入"评级,目标价从40美元升至42美元
今天 16:34
UBS analyst Josh Silverstein maintains Weatherford International (NASDAQ:WFRD) with a Neutral and raises the price target from $94 to $105.
今天 04:02
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31
Crude near $100 as Iran's leader demands prolonged Hormuz closure and traders abandon bets on 2026 Fed rate cuts.
03-13 00:54
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Weatherford International (NASDAQ:WFRD) has been analyzed by 7 analysts in the ...
03-05 03:01
Goldman Sachs analyst Atidrip Modak maintains Weatherford International (NASDAQ:WFRD) with a Neutral and raises the price target from $83 to $107.
03-05 00:14
Citigroup analyst Scott Gruber maintains Weatherford International (NASDAQ:WFRD) with a Buy and raises the price target from $93 to $115.
02-14 02:43
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
UBS analyst Josh Silverstein maintains Weatherford International (NASDAQ:WFRD) with a Neutral and raises the price target from $82 to $94.
02-05 23:26